MRK  Merck & Company Inc.

Exchange

NYSE

Sector

Consumer Durables

Industry

Major Pharmaceuticals

Market Cap.

173.4B

Vuru Grade

47.84/100

Current Price

$60.11
+0.11 (+0.18%)

Growth Price

$46.97
Overvalued by 21.87%

Stability Price

$23.37
Overvalued by 61.12%

Company Metrics

  • 31.61 P/E
  • 3.97 P/S
  • 3.6 P/B
  • 1.898 EPS
  • 10.80% Cash ROIC
  • 0.98 Cash Ratio
  • 1.75 / 2.92% Dividend
  • 8.12M Avg. Vol.
  • 2.88B Shares
  • 173.4B Market Cap.

Company Description

Merck & Co., Inc. provides various health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. The company's Pharmaceutical segment provides human health pharmaceutical products, such as therapeutic and preventive agents for the treatment of human disorders in the areas of bone, respiratory, immunology, dermatology, cardiovascular, ...
more


Download 10 Years of Financial Statements:
Income Statement   Balance Sheet   Cash Flow

News

3 Reasons Merck & Co., Inc.'s Stock Could Fall
Motley Fool - Aug 28, 2014
If you were lucky enough to time your purchase of Merck (NYSE: MRK ) during the heights of the Great Recession, your investment has probably seen a return of 100% or greater.
The New York Times Company (NYT), Citigroup Inc (C) and Merck & Co., Inc ...
StockWise Daily - 16 hours ago
According to the latest 13F SEC filing from the Kahn Brothers, the New York Times Company (NYSE:NYT), Citigroup Inc (NYSE:C), and Merck & Co., Inc. (NYSE:MRK) are three major holdings of the company. With a fund value of $687 million, Kahn Brothers ...
Merck & Co. Inc. (MRK) Tops DJIA Gainers for August 22
Equities.com - Aug 22, 2014
The Dow closed at 17,001.20 on Friday, which is a -0.22% move from yesterday's close. Merck & Co. Inc. led all gainers with a 0.54% jump.
Merck & Co. Inc. (MRK) Among Biggest DJIA Losers on August 18
Equities.com - Aug 18, 2014
Shares of Merck & Co. Inc. led all laggers on the Dow Monday with a decline of 0.32%. The DJIA closed at 16,838.70, which is a 1.06% change from the previous day's close.
Merck & Co. Inc. (MRK) Among Biggest DJIA Losers on August 21
Equities.com - Aug 21, 2014
Shares of Merck & Co. Inc. led all laggers on the Dow Thursday with a decline of 1.06%. The DJIA closed at 17,039.60, which is a 0.36% change from the previous day's close.
Why Wall Street Is Not Bearish On Merck
Bidness Etc - Aug 21, 2014
Merck has been involved in a number of research projects during the year, and acquired Idenix Pharmaceuticals Inc. (IDIX) in July.
Wednesday's Analyst Moves: Pfizer Inc., Merck & Co., Inc., Bristol-Myers ...
Dividend.com - Aug 27, 2014
Deutsche Bank has initiated coverage on Eli Lilly and Co (LLY ) with a “Buy” rating and a $71 price target. This price target suggests an 11% increase from the stock's current price.
Pfizer Inc. (NYSE:PFE)'s Xalkori Move To Next Level With Collaboration As ... - eMarketsDaily
3 Reasons Merck & Co., Inc.'s Stock Could Rise
NASDAQ - Aug 19, 2014
For investors lucky enough to have jumped into Merck in 2009 at the tail end of the Great Recession you've seen an appreciation in your shares of near 100%.
5 Things Merck & Co., Inc.'s Management Wants You to Know
NASDAQ - Aug 11, 2014
In its second-quarter earnings results, released just two weeks ago, Merck reported a 1% decline in worldwide sales to $10.9 billion from the year-ago period, weighed-down by patent expirations and increasing competition, as its adjusted earnings per ...
Company Update: Merck & Co Inc (NYSE:MRK) – [video] Merck & Pfizer team up
Jutia Group - Aug 27, 2014
Summary (NYSE:MRK) : Merck & Co., Inc. provides various health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products worldwide.
Deutsche Bank Initiates Coverage on Merck & Co. (MRK) - WKRB News
Active Stocks: Merck & Co. Inc. (NYSE:MRK), Travelzoo Inc. (NASDAQ:TZOO ... - eFinance Hub